REGISTRIES: Innovaderm ANB019-401


ANB019-401: An international, multicenter, prospective registry of patients with generalized pustular psoriasis (GPP). Clinical trial for adults (age > 18) with clinically confirmed diagnosis [...]

REGISTRIES: Innovaderm ANB019-4012022-03-04T15:18:43+00:00



ASLAN004-003: A randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe atopic dermatitis. [...]

ATOPIC DERMATITIS: ASLAN004-0032022-03-29T20:32:51+00:00

What is a Registry?


This is an observational study where patients are followed to track treatments (medications, efficacy, length of time used), side effects, complications, and other medications & [...]

What is a Registry?2021-06-02T16:07:18+00:00

What is a long-term extension?


A long-term extension follows an initial study. All patients on these studies will receive medications, typically for a longer time period of one to several [...]

What is a long-term extension?2021-05-25T17:40:41+00:00

How we measure body surface area (BSA)?


BSA is determined by measuring the number of handprints of involvement present. A handprint includes the palm and the fingers as shown in the image. [...]

How we measure body surface area (BSA)?2021-06-22T20:36:32+00:00

What is a placebo?


A placebo is a treatment containing all compounds present in the investigational product except the active ingredient. It is necessary in clinical trials to [...]

What is a placebo?2021-06-02T16:06:00+00:00

Will MDRI diagnose my condition?


Typically studies will require a clinical diagnosis prior to enrollment, and will request medical records from patients to affirm the date of diagnosis. [...]

Will MDRI diagnose my condition?2021-05-25T17:37:20+00:00